Should Students Carry Naloxone? AMA Members Debate Policy Stance Delegates also examine role in preventing border wall injuries and recidivism in jails, prisons Jun 12, 2023
Kratom Linked to Outsized Proarrhythmic Risks OTC agents are not safe alternatives to prescription opioids, study suggests Jun 05, 2023
'If the Narcan Isn't Working, Give More' and Other Myths About Naloxone Use In non-responsive patients, think polysubstance use, says addiction treatment expert Kelly Ramsey Jun 02, 2023
House Passes Bill to Address Fentanyl Overdoses But critics say the HALT Fentanyl Act is the wrong way to approach the problem May 26, 2023
OUD Treatment Disparities Persisted for Reproductive-Age Women Black women less likely to start buprenorphine May 23, 2023
New Type of Opioid Reversal Agent Approved Longer-acting nasal spray to be available by end of the year May 23, 2023
The Opioid Treatment Dilemma in Jails It comes down to funding -- but it's time for that to change May 20, 2023
Addiction Doc Urges Lawmakers to Rethink Methadone Prescribing Restrictions Suicide prevention in traumatic brain injury survivors also on the docket during hearing May 18, 2023
Vibrating Crib Mattress Eases Opioid Withdrawal for Exposed Infants "A great need to reduce medication treatment in this vulnerable population," says researcher May 15, 2023
DEA: Clarify Your Stance on Harm Reduction Legal ambiguity is preventing doctors from best serving patients May 15, 2023
Bill to Study Xylazine Passes House, Advances in Senate Measure does not address scheduling the drug, which is frequently added to fentanyl May 12, 2023
Atlanta Hospital Shooting; Copycat Ozempic; DEA Extends Telemedicine Prescribing Health news and commentary from around the Web gathered by 51˶ staff May 04, 2023
CDC: Fentanyl Overdose Deaths Increased 279% Over Recent Years Overdoses involving heroin and oxycodone fell during this time May 03, 2023
FDA Panelists Slam Agency's Proposed Opioid Trial Design Advisors said outcomes from an enriched enrollment study would not be broadly generalizable Apr 20, 2023
FDA Mulling Trial Design Issues for Long-Term Opioids in Chronic Pain Agency advisors will consider pros, cons of an enriched enrollment randomized withdrawal design Apr 17, 2023
We're Treating Low Back Pain All Wrong Let's reexamine the current approach to treatment Apr 14, 2023
All Opioid Pain Meds to Get New Safety Warnings, FDA Says Updated labeling to include warning about opioid-induced hyperalgesia Apr 13, 2023
Chronic Pain Affects 21% of Americans, CDC Reports Nearly 7% have pain severe enough to restrict daily activities Apr 13, 2023
Training Program Leads to More Buprenorphine Use in ED Intensive healthcare education also tied to better OUD treatment engagement Apr 05, 2023
New DEA License Requirement Starts in June The X waiver is gone, but clinicians may need new training to renew their DEA license Apr 05, 2023
U.S. 'Flying Blind' When It Comes to Data on Substance Use in Pregnancy Limited data "makes people think that the problem doesn't exist" Mar 31, 2023
Mothers Face Broken Addiction Treatment System Lack of comprehensive care puts pregnant, postpartum people with substance use disorder at risk Mar 31, 2023
Use of EMR Directive Tied to Reduced Opioid Prescribing After Spine Surgery Small study shows drop in average number of pills at discharge Mar 27, 2023
Life-Saving Telehealth for Opioid Use Disorder Hangs in the Balance The U.S. could soon face a preventable public health crisis Mar 14, 2023
FDA Mandate on Acetaminophen-Opioid Combinations Appeared Effective Hospitalizations for liver toxicity declined after FDA limited acetaminophen dose Mar 07, 2023
Cancer-Free Medicare Recipients Received Fentanyl Indicated for Cancer Pain These prescriptions could lead to abuse, OIG report warns Mar 02, 2023
FDA Issues Import Alert on 'Tranq' Drug Xylazine Drug will be under added scrutiny to make sure it's for "legitimate veterinary use," agency says Feb 28, 2023
Will Xylazine Become a Controlled Substance? Federal regulators consider scheduling the veterinary sedative Feb 23, 2023
Over-the-Counter Naloxone Has the Power to Save Lives But removing barriers to access is an essential next step Feb 23, 2023
What Clinicians Need to Know About Loperamide Misuse While cases have declined, use of loperamide as an opioid substitute still poses serious risks Feb 22, 2023
Proposed User Instructions for OTC Narcan Has FDA Concerned In emergency setting, proper use and administration by consumer is "essential," says agency staff Feb 14, 2023
Buprenorphine for Chronic Pain, Not Full Agonist Opioids, New VA Guidance Says Unintended consequences of the recommendation need to be evaluated, experts maintain Feb 13, 2023
Cannabis May Interfere With Pregnancy Retrospective study finds exposure linked with higher rates of stillbirth, hypertensive disorders Feb 10, 2023
Biden Pledges to Extend Medicare's Solvency for 'At Least Two Decades' Healthcare featured prominently in president's State of the Union address Feb 08, 2023
Republican Lawmakers Worry X-Waiver Elimination Could Stir Buprenorphine Diversion House members also look for ways to stop drug trafficking on Snapchat Feb 02, 2023
What Doctors Should Know About Xylazine in Fentanyl Naloxone still works but additional support may be needed; wound care a challenge Feb 01, 2023
When Surgeons Clamp Down on Opioids After Cardiac Operations Pain control feasible even when dropping to zero opioids Jan 22, 2023
Fewer Emergency Department Visits End With Opioid Prescriptions 8% of ED patients have an opioid prescribed at discharge Jan 20, 2023
Pregnant Women With Syphilis, Substance Use More Likely to Pass Infection to Babies Prompt treatment of syphilis needed to reduce poor outcomes, but many passed on prenatal care Jan 19, 2023
More Evidence to Support Restrictive Opioid Prescribing After Cancer Surgery Significant decreases in prescription days, doses, refill requests, with few patient complaints Jan 06, 2023
